Skip to Content

MN-REACH Seeks Med-Tech, Pharma Projects for Third Funding Cycle

Close up of different pills

An upcoming funding opportunity will help researchers who have developed cutting-edge medical technologies or pharmaceuticals bring these discoveries to market.

The University of Minnesota’s MN-REACH program, a National Institutes of Health’s Research Evaluation and Commercialization Hub, is accepting pre-proposals for its third funding cycle to help commercialize new med-tech and pharma inventions. MN-REACH aims to improve health care by fostering the development of breakthrough lab innovations — such as therapeutics, preventatives, diagnostics, devices and tools — into products that create health, economic and societal benefits.

Researchers can submit pre-proposals for MN-REACH Cycle 3 funding from Monday, Jan. 25 through Thursday, Feb. 11. The following informational sessions will review eligibility for the program and the application process:

  • U of M Duluth: Jan. 27, 11 a.m. to noon, 160 Life Sciences Building
  • East Bank: Jan. 28, mid-morning (to be determined), Moos Tower
  • St. Paul: Jan. 29, 1-2 p.m., 125 Coffey Hall

See the list of projects selected for MN-REACH funding during Cycle 1. Awardees of Cycle 2 grants will be announced in February.

Skills Development

In addition to providing funding opportunities to commercialize innovations, MN-REACH also provides educational opportunities for innovators that are developing their products and forming new partnerships both within and beyond the University.

Registration is now open for the free Medical Technology Commercialization Bootcamp. University faculty, staff and student health care researchers are invited to attend to learn about the commercialization process and the resources available to support bringing an innovation to market. The seminar will be held from 9 a.m. to 4 p.m. on Wednesday, Feb. 3 at the Mayo Building.

Contact mn-reach@umn.edu with questions.

Kevin Coss

Kevin Coss

Kevin is a writer with the Office of the Vice President for Research.

coss@umn.edu

Latest Blog Posts

Natural killer cell

A biotech startup created to bring new cancer therapies to life has attracted high levels of funding during its early-stage investment rounds.

Read More
Graphic reading "Minnesota's Tekne Awards, Wednesday, Nov. 18"

The Tekne Awards, hosted by the Minnesota Technology Association, highlight the many people and companies driving technology innovation across the state.

Read More
Categories:
Graphic of speech bubbles surrounding book covers

Manifold Scholarship is a digital platform that enables publishers to quickly and easily create interactive, media-rich digital publications.

Read More
Close-up view of a stack of academic journals

An analysis of citation counts by Clarivate Analytics shows nearly two dozen UMN faculty are among the most influential researchers in their fields.

Read More
Categories: